Therefore, the biased ligands for MC4R that selectively activate Gαq signaling to decrease food intake but not trigger Gαs signaling with cardiovascular side effects might be better drug candidates for obesity treatment [21]. The gene discussed is MC4R; the disease is obesity due to melanocortin 4 receptor deficiency.